11-45805149-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_018389.5(SLC35C1):c.-653C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00416 in 986,534 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0034 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0043 ( 8 hom. )
Consequence
SLC35C1
NM_018389.5 5_prime_UTR
NM_018389.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0940
Genes affected
SLC35C1 (HGNC:20197): (solute carrier family 35 member C1) This gene encodes a GDP-fucose transporter that is found in the Golgi apparatus. Mutations in this gene result in congenital disorder of glycosylation type IIc. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00342 (520/152074) while in subpopulation NFE AF= 0.00524 (356/67930). AF 95% confidence interval is 0.00479. There are 2 homozygotes in gnomad4. There are 268 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC35C1 | NM_018389.5 | c.-653C>T | 5_prime_UTR_variant | 1/2 | ENST00000314134.4 | NP_060859.4 | ||
SLC35C1 | XM_011520203.4 | c.-653C>T | 5_prime_UTR_variant | 1/2 | XP_011518505.1 | |||
SLC35C1 | NM_001145265.2 | c.-32+632C>T | intron_variant | NP_001138737.1 | ||||
SLC35C1 | NM_001145266.1 | c.-31-661C>T | intron_variant | NP_001138738.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC35C1 | ENST00000314134.4 | c.-653C>T | 5_prime_UTR_variant | 1/2 | 1 | NM_018389.5 | ENSP00000313318 | P4 | ||
SLC35C1 | ENST00000442528.2 | c.-32+632C>T | intron_variant | 1 | ENSP00000412408 | A1 | ||||
SLC35C1 | ENST00000530471.1 | c.-199C>T | 5_prime_UTR_variant | 1/2 | 3 | ENSP00000432669 | ||||
SLC35C1 | ENST00000526817.2 | c.-31-661C>T | intron_variant | 2 | ENSP00000432145 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00342 AC: 520AN: 151956Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
520
AN:
151956
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00430 AC: 3587AN: 834460Hom.: 8 Cov.: 30 AF XY: 0.00435 AC XY: 1678AN XY: 385492
GnomAD4 exome
AF:
AC:
3587
AN:
834460
Hom.:
Cov.:
30
AF XY:
AC XY:
1678
AN XY:
385492
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00342 AC: 520AN: 152074Hom.: 2 Cov.: 33 AF XY: 0.00360 AC XY: 268AN XY: 74346
GnomAD4 genome
AF:
AC:
520
AN:
152074
Hom.:
Cov.:
33
AF XY:
AC XY:
268
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Leukocyte adhesion deficiency type II Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at